Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review

BACKGROUND: Rapid improvements in hepatitis C virus (HCV) therapy have led to the approval of multiple oral direct-acting antiviral (DAA) regimens by the U.S. Food and Drug Administration (FDA) for treatment of chronic HCV infection. PURPOSE: To summarize published literature on the efficacy and saf...

Full description

Saved in:
Bibliographic Details
Published in:Ann Intern Med
Main Authors: Falade-Nwulia, Oluwaseun, Suarez-Cuervo, Catalina, Nelson, David R., Fried, Michael W., Segal, Jodi B., Sulkowski, Mark S.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486987/
https://ncbi.nlm.nih.gov/pubmed/28319996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M16-2575
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items